Qianrui Li
- Nephrology top 5%
-
- Hormonal Regulation and Hypertension 5
- Rheumatology top 10%
-
- Botulinum Toxin and Related Neurological Disorders 3
-
- Health Systems, Economic Evaluations, Quality of Life 8
-
- Meta-analysis and systematic reviews 8
-
- Advanced Causal Inference Techniques 5
- Statistical Methods in Clinical Trials 5
-
- Adrenal and Paraganglionic Tumors 5
-
- Clinical practice guidelines implementation 4
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Qianrui Li
49 papers receiving 826 citations
Peers
Comparison fields: 5 of 113
- Nephrology 124
- Endocrinology, Diabetes and Metabolism 173
- Rheumatology 147
- Neurology 68
- Pathology and Forensic Medicine 66
Countries citing papers authored by Qianrui Li
This map shows the geographic impact of Qianrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianrui Li more than expected).
Fields of papers citing papers by Qianrui Li
This network shows the impact of papers produced by Qianrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianrui Li. The network helps show where Qianrui Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qianrui Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 0 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 5 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 116 | |
| 13 | 2019 | 10 | |
| 14 | 2018 | 79 | |
| 15 | 2018 | 13 | |
| 16 | 2017 | 24 | |
| 17 | 2017 | 7 | |
| 18 | 2016 | 18 | |
| 19 | Primary hypertrophic osteoarthropathy with myelofibrosis and anemia: a case report and review of literature. | 2015 | 9 |
| 20 | 1990 | 2 |
About Qianrui Li
Qianrui Li is a scholar working on Statistics, Probability and Uncertainty, Endocrinology, Diabetes and Metabolism and Statistics and Probability, having authored 57 papers that have together received 836 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Meta-analysis and systematic reviews (8 papers), Advanced Causal Inference Techniques (5 papers), Statistical Methods in Clinical Trials (5 papers), Adrenal and Paraganglionic Tumors (5 papers), Hormonal Regulation and Hypertension (5 papers), Clinical practice guidelines implementation (4 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). The work is most often cited by research in Nephrology (124 citations), Endocrinology, Diabetes and Metabolism (173 citations) and Rheumatology (147 citations). Qianrui Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Sheyu Li, Xin Sun, Haoming Tian, Ling Li, Yunfeng Lin, W. F. Mader, Ximing Shao, Sanjun Shi, Dan Zhao and Xiaodan Li.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.